Molecular Metabolism · 2014 · 11 citations · 18 references
MedicineEndocrinologyPhysiologyCell SignalingMetabolic RegulationPharmacogeneticsDiabetes MellitusHormone Receptor GeneticsInsulin ResistanceNuclear Receptor SignalingReceptor PolymorphismsGlucose-dependent Insulin SecretionGlucose-stimulated Insulin SecretionImpaired Glucose TolerancePeroxisome Proliferator-activated Receptor Gamma AgonismPeroxisome Proliferator-activated Receptor Gamma RegulationPeroxisome Proliferator-activated Receptor GeneticsPeroxisome Proliferator-activated Receptor SignalingPeroxisome Proliferator-activated Receptors
Genetic variation in FFAR1 modulates insulin secretion dependent on non-esterified fatty acid (NEFA) concentrations. We previously demonstrated lower insulin secretion in minor allele carriers of PPARG Pro12Ala in high-NEFA environment, but the mode of action could not been revealed. We tested if this effect is mediated by FFAR1 in humans. Subjects with increased risk of diabetes who underwent oral glucose tolerance tests were genotyped for 7 tagging SNPs in FFAR1 and PPARG Pro12Ala. The FFAR1 SNPs rs12462800 and rs10422744 demonstrated interactions with PPARG on insulin secretion. FFAR1 rs12462800 (p = 0.0006) and rs10422744 (p = 0.001) were associated with reduced insulin secretion in participants concomitantly carrying the PPARG minor allele and having high fasting FFA. These results suggest that the minor allele of the PPARG SNP exposes its carriers to modulatory effects of FFAR1 on insulin secretion. This subphenotype may define altered responsiveness to FFAR1-agonists, and should be investigated in further studies.
18
Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40
Yasuaki Itoh, Yuji Kawamata, Masataka Harada et al. · Nature · 2003 · 1.5K citations
Holbrooke S. Seltzer, Elsie Allen, Arthur L Herron et al. · Journal of Clinical Investigation · 1967 · 831 citations · Full text
Sangeeta Kashyap, Renata Belfort, Amalia Gastaldelli et al. · Diabetes · 2003 · 503 citations · Full text